KULKARNI SAMARTH (Chief Executive Officer) sold 4.0% of their position (10.35K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $499.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/17/2026ACC: 0001193125-26-111278
DirectorOfficer· Chief Executive Officer
Since Sep 2018
-10.35K
Net shares
Net seller
$499.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20.63K acquired · 30.97K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+20.63K
Price / share
—
Trade value
—
% of position
8.8%
3/14/2026
235.56K→256.18K
Common Shares
Direct
Shares
−10.35K
Price / share
$48.26
Trade value
$499.44K
% of position
4.0%
3/16/2026
256.18K→245.83K
Total
Net shares
+10.28K
Net value
-$499.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/14/2026 | M · Option Exercise | +20.63K | — | — | 8.8% | 235.56K | 256.18K |
| Common Shares Direct | 3/16/2026 | S · Sale | −10.35K | $48.26 | $499.44K | 4.0% | 256.18K | 245.83K |
| Total | +10.28K | -$499.44K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Shares
20.63K shares
Shares
−20.63K
Strike price
Held after
61.88K
Exercisable
—
3/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares20.63K shares | 3/14/2026 | M · Option Exercise | −20.63K | — | 61.88K |